Establishment, functional and genetic characterization of three novel patient-derived rectal cancer cell lines

被引:7
|
作者
Gock, Michael [1 ]
Mullins, Christina S. [2 ]
Bergner, Carina [3 ]
Prall, Friedrich [4 ]
Ramer, Robert [5 ]
Goeder, Anja [6 ]
Kraemer, Oliver H. [6 ]
Lange, Falko [7 ]
Krause, Bernd J. [3 ]
Klar, Ernst [1 ]
Linnebacher, Michael [2 ]
机构
[1] Univ Med Ctr, Dept Gen Surg, D-18055 Rostock, Germany
[2] Univ Med Ctr, Sect Mol Oncol & Immunotherapy, D-18055 Rostock, Germany
[3] Univ Med Ctr, Dept Nucl Med, D-18055 Rostock, Germany
[4] Univ Med Ctr, Inst Pathol, D-18055 Rostock, Germany
[5] Univ Med Ctr, Inst Pharmacol, D-18055 Rostock, Germany
[6] Univ Med Ctr Mainz, Inst Toxicol, D-55131 Mainz, Germany
[7] Univ Med Ctr, Oscar Langendorff Inst Physiol, D-18055 Rostock, Germany
关键词
Patient-derived tumor model; Rectal cancer; F-18-fluorodeoxyglucose; F-18-fluorothymidine; FOLFOX; FOLFIRI; Personalized medicine; ISLAND METHYLATOR PHENOTYPE; COLORECTAL-CANCER; PREOPERATIVE CHEMORADIOTHERAPY; PI3K/PTEN/AKT/MTOR PATHWAY; MOLECULAR SUBTYPES; TUMOR RESPONSE; RADIOCHEMOTHERAPY; 5-FLUOROURACIL; IDENTIFICATION; PREDICTION;
D O I
10.3748/wjg.v24.i43.4880
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
AIM To establish patient-individual tumor models of rectal cancer for analyses of novel biomarkers, individual response prediction and individual therapy regimens. METHODS Establishment of cell lines was conducted by direct in vitro culturing and in vivo xenografting with subsequent in vitro culturing. Cell lines were in-depth characterized concerning morphological features, invasive and migratory behavior, phenotype, molecular profile including mutational analysis, protein expression, and confirmation of origin by DNA fingerprint. Assessment of chemosensitivity towards an extensive range of current chemotherapeutic drugs and of radiosensitivity was performed including analysis of a combined radio-and chemotherapeutic treatment. In addition, glucose metabolism was assessed with F-18-fluorodeoxyglucose (FDG) and proliferation with F-18-fluorothymidine. RESULTS We describe the establishment of ultra-low passage rectal cancer cell lines of three patients suffering from rectal cancer. Two cell lines (HROC126, HROC284Met) were established directly from tumor specimens while HROC239 T0 M1 was established subsequent to xenografting of the tumor. Molecular analysis classified all three cell lines as CIMP-0/ non-MSI-H (sporadic standard) type. Mutational analysis revealed following mutational profiles: HROC126: APC(wt), TP53(wt), KRAS(wt), BRAP(wt), PTENwt; HROC239 TO M1 : APC(mut), P53(wt), KRAS(mut), BRAF(wt), PTENmut and HROC284Met: APC(wt), P53(mut), KRAS(mut), BRAF(wt), PTENmut. All cell lines could be characterized as epithelial (EpCAM(+)) tumor cells with equivalent morphologic features and comparable growth kinetics. The cell lines displayed a heterogeneous response toward chemotherapy, radiotherapy and their combined application. HROC126 showed a highly radio-resistant phenotype and HROC284Met was more susceptible to a combined radiochemotherapy than HROC126 and HROC239 T0 M1. Analysis of F-18-FDG uptake displayed a markedly reduced FDG uptake of all three cell lines after combined radiochemotherapy. CONCLUSION These newly established and in-depth characterized ultra-low passage rectal cancer cell lines provide a useful instrument for analysis of biological characteristics of rectal cancer.
引用
收藏
页码:4880 / 4892
页数:13
相关论文
共 50 条
  • [31] Establishment and characterization of two novel patient-derived lines from canine high-grade glioma
    Schrock, Morgan S.
    Zalenski, Abigail A.
    Tallman, Miranda M.
    Kollin, Luke
    Bratasz, Anna
    Weeks, Griffin
    Miller, Margaret A.
    Sweeney, Courtney N.
    Pluhar, G. Elizabeth
    Olin, Michael R.
    Kisseberth, William C.
    Bentley, R. Timothy
    Dickinson, Peter J.
    York, Daniel
    Webb, Amy
    Wang, Xu
    Moore, Sarah
    Venere, Monica
    Summers, Matthew K.
    VETERINARY AND COMPARATIVE ONCOLOGY, 2023, 21 (03) : 492 - 502
  • [32] CHARACTERIZATION OF PATIENT-DERIVED PRIMARY CELL LINES AND XENOGRAFTS FOR GLIOBLASTOMA
    Kijima, Noriyuki
    Kanematsu, Daisuke
    Shofuda, Tomoko
    Nonaka, Masahiro
    Iwata, Ryoichi
    Fukai, Junya
    Inoue, Akihiro
    Sasayama, Takashi
    Tsuyuguchi, Naohiro
    Kawashima, Toshiyuki
    Higuchi, Yuichiro
    Suemizu, Hiroshi
    Mori, Kanji
    Kishima, Haruhiko
    Kanemura, Yonehiro
    NEURO-ONCOLOGY, 2019, 21 : 262 - 262
  • [33] Establishment and characterization of two novel patient-derived organoid xenograft models of advanced prostate cancer
    Servant, R.
    Diamantopoulou, Z.
    Garioni, M.
    Roma, L.
    Vlajnic, T.
    Templeton, A. J.
    Pueschel, H.
    Piscuoglio, S.
    Aceto, N.
    Bubendorf, L.
    Seifert, H.
    Rentsch, C. A.
    Le Magnen, C.
    EUROPEAN UROLOGY, 2022, 81 : S633 - S633
  • [34] Establishment and characterization of two novel patient-derived organoid xenograft models of advanced prostate cancer
    Servant, Raphaelle
    Diamantopoulou, Zoi
    Garioni, Michele
    Roma, Luca
    Vlajnic, Tatjana
    Templeton, Arnoud J.
    Pueschel, Heike
    Piscuoglio, Salvatore
    Aceto, Nicola
    Seifert, Helge
    Rentsch, Cyrill A.
    Lukas, Bubendorf
    Le Magnen, Clementine
    CANCER RESEARCH, 2022, 82 (12)
  • [35] Establishment and characterization of NCC-MFS2-C1: a novel patient-derived cancer cell line of myxofibrosarcoma
    Rei Noguchi
    Yuki Yoshimatsu
    Takuya Ono
    Akane Sei
    Kaoru Hirabayashi
    Iwao Ozawa
    Kazutaka Kikuta
    Tadashi Kondo
    Human Cell, 2021, 34 : 246 - 253
  • [36] Establishment and characterization of NCC-LMS2-C1—a novel patient-derived cancer cell line of leiomyosarcoma
    Rei Noguchi
    Yuki Yoshimatsu
    Takuya Ono
    Akane Sei
    Kaoru Hirabayashi
    Iwao Ozawa
    Kazutaka Kikuta
    Tadashi Kondo
    Human Cell, 2021, 34 : 279 - 288
  • [37] Establishment and characterization of NCC-MFS2-C1:a novel patient-derived cancer cell line of myxofibrosarcoma
    Noguchi, Rei
    Yoshimatsu, Yuki
    Ono, Takuya
    Sei, Akane
    Hirabayashi, Kaoru
    Ozawa, Iwao
    Kikuta, Kazutaka
    Kondo, Tadashi
    HUMAN CELL, 2021, 34 (01) : 246 - 253
  • [38] Establishment and characterization of NCC-LMS2-C1-a novel patient-derived cancer cell line of leiomyosarcoma
    Noguchi, Rei
    Yoshimatsu, Yuki
    Ono, Takuya
    Sei, Akane
    Hirabayashi, Kaoru
    Ozawa, Iwao
    Kikuta, Kazutaka
    Kondo, Tadashi
    HUMAN CELL, 2021, 34 (01) : 279 - 288
  • [39] Establishment and characterization of meningioma patient-derived organoid
    Chan, Henry Siu Cheung
    Ng, Ho Keung
    Chan, Aden Ka-Yin
    Ha Cheng, Sau
    Chow, Chit
    Wong, Nathalie
    Wong, George Kwok Chu
    JOURNAL OF CLINICAL NEUROSCIENCE, 2021, 94 : 192 - 199
  • [40] Genetic and Genomic Characterization of 462 Melanoma Patient-Derived Xenografts, Tumor Biopsies, and Cell Lines
    Garman, Bradley
    Anastopoulos, Ioannis N.
    Krepler, Clemens
    Brafford, Patricia
    Sproesser, Katrin
    Jiang, Yuchao
    Wubbenhorst, Bradley
    Amaravadi, Ravi
    Bennett, Joseph
    Beqiri, Marilda
    Elder, David
    Flaherty, Keith T.
    Frederick, Dennie T.
    Gangadhar, Tara C.
    Guarino, Michael
    Hoon, David
    Karakousis, Giorgos
    Liu, Qin
    Mitra, Nandita
    Petrelli, Nicholas J.
    Schuchter, Lynn
    Shannan, Batool
    Shields, Carol L.
    Wargo, Jennifer
    Wenz, Brandon
    Wilson, Melissa A.
    Xiao, Min
    Xu, Wei
    Xu, Xaiowei
    Yin, Xiangfan
    Zhang, Nancy R.
    Davies, Michael A.
    Herlyn, Meenhard
    Nathanson, Katherine L.
    CELL REPORTS, 2017, 21 (07): : 1936 - 1952